BNF for Children January 2023 Update

This update contains 2 significant changes, 1 dose change, 2 new monographs and 1 new preparation.

Significant Changes:

• Contraceptives, interactions: updated guidance.
• Oropharyngeal infections, antibacterial therapy: updated guidance for the management of acute sore throat.

Dose Changes:

• Dupixent® (dupilumab) [update to include dosing in children from 6 years old for severe asthma with type 2 inflammation].

New Monographs:

• Drovelis® [drospirenone with estetrol].
• Lucentis® [ranibizumab].

New Preparation:

• Efmody® [hydrocortisone].